Med School: Separating Hype from Hope in Genome Science

Genomic discoveries were supposed to transform medicine and move us to a new vision of preventive health care. But 15 years after the Human Genome Project was complete, that still hasn’t happened. Meanwhile, direct-to-consumer genetics companies are bypassing health care providers to market ancestry, disease risk, diet, exercise and even dating and wine applications directly to the public. Robert Green, one of the world’s leaders in generating the evidence-base for genomic medicine, describes what's right and what’s wrong with the genomic revolution, and how we can realize the promise of precision medicine for all.
(Underwritten by America's Biopharmaceutical Companies)

Speakers: Robert C. Green
Festival: Spotlight Health 2018

Watch and Listen: Health

Women with early-stage breast cancer may not need any chemotherapy. That’s the treatment-transforming finding from just... See more
Illness and death are universal challenges, but not something we anticipate in our 30s. Kate Bowler and Lucy Kalanithi... See more
College presents opportunities for students to test their wings, explore new relationships, pursue their personal best... See more
Over the past 20 years, almost 200,000 children under age 18 have been shot. Nearly as many attend schools where a... See more
Rural residents photograph ailing chickens to monitor the spread of Avian flu, mountaineer adventurers collect scat... See more
Racial segregation and uneven access to opportunity are powerful obstacles to upward mobility in the US, contributing... See more

Pages